Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Rimke C. Vos is active.

Publication


Featured researches published by Rimke C. Vos.


PLOS ONE | 2016

Diabetes-Related Distress, Depression and Distress-Depression among Adults with Type 2 Diabetes Mellitus in Malaysia

Boon How Chew; Rimke C. Vos; Sherina Mohd-Sidik; Guy E.H.M. Rutten

Type 2 diabetes mellitus (T2DM) brings about an increasing psychosocial problem in adult patients. Prevalence data on and associated factors of diabetes related distress (DRD) and depression have been lacking in Asia. This study aimed to examine the prevalence of DRD and depression, and their associated factors in Asian adult T2DM patients. This study was conducted in three public health clinics measuring DRD (Diabetes Distress Scale, DDS), and depression (Patient Health Questionnaire, PHQ). Patients who were at least 30 years of age, had T2DM for more than one year, with regular follow-up and recent laboratory results (< 3 months) were consecutively recruited. Associations between DRD, depression and the combination DRD-depression with demographic and clinical characteristics were analysed using generalized linear models. From 752 invited people, 700 participated (mean age 56.9 years, 52.8% female, 52.9% Malay, 79.1% married). Prevalence of DRD and depression were 49.2% and 41.7%, respectively. Distress and depression were correlated, spearman’s r = 0.50. Patients with higher DRD were younger (OR 0.995, 95% CI 0.996 to 0.991), Chinese (OR 1.2, 95% CI 1.04 to 1.29), attending Dengkil health clinic (OR 1.1, 95% CI 1.00 to 1.22) and had higher scores on the PHQ (OR 1.1, 95% CI 1.04 to 1.06). Depression was less likely in the unmarried compared to divorced/separately living and those attending Dengkil health clinic, but more likely in patients with microvascular complications (OR 1.4, 95% CI 1.06 to 1.73) and higher DDS (OR 1.03, 95% CI 1.02 to 1.03). For the combination of DRD and depression, unemployment (OR 4.7, 95% CI 1.02 to 21.20) had positive association, whereas those under medical care at the Salak health clinics (OR 0.28, 95% CI 0.12 to 0.63), and those with a blood pressure > 130/80 mmHg (OR 0.53, 95% CI 0.32 to 0.89) were less likely to experience both DRD and depression. DRD and depression were common and correlated in Asian adults with T2DM at primary care level. Socio-demographic more than clinical characteristics were related to DRD and depression.


Diabetic Medicine | 2015

Diabetes-related distress over the course of illness : results from the Diacourse study

Marise Kasteleyn; L. de Vries; A. L. van Puffelen; F.G. Schellevis; Mieke Rijken; Rimke C. Vos; Guy E.H.M. Rutten

To investigate the relationship between diabetes duration and diabetes‐related distress and to examine the impact of micro‐ and macrovascular complications and blood glucose‐lowering treatment on this relationship.


Developmental Medicine & Child Neurology | 2016

Efficacy of three therapy approaches in preschool children with cerebral palsy: a randomized controlled trial.

Anne J A Kruijsen-Terpstra; Marjolijn Ketelaar; Olaf Verschuren; Jan Willem Gorter; Rimke C. Vos; Johannes Verheijden; Marian J. Jongmans; Anne Visser-Meily

To examine the efficacy of child‐focused, context‐focused, and regular care approaches, delivered in a rehabilitation setting by physical or occupational therapists to preschool children with cerebral palsy (CP), in optimizing the childs self‐care and mobility capabilities.


Diabetic Medicine | 2016

Effectiveness of tailored support for people with Type 2 diabetes after a first acute coronary event: a multicentre randomized controlled trial (the Diacourse‐ACE study)

Marise Kasteleyn; Rimke C. Vos; Mieke Rijken; F.G. Schellevis; Guy E.H.M. Rutten

To evaluate the effectiveness of a tailored, supportive intervention strategy in influencing diabetes‐related distress, health status, well‐being and clinical outcomes in people with Type 2 diabetes shortly after a first acute coronary event.


BMC Public Health | 2015

Comparison of perceptions of obesity among adults with central obesity with and without additional cardiometabolic risk factors and among those who were formally obese, 3 years after screening for central obesity.

Corine den Engelsen; Rimke C. Vos; Mieke Rijken; Guy E.H.M. Rutten

BackgroundPerceptions of illness are important determinants of health behaviour. A better understanding of perceptions of obesity might allow more effective interventions that challenge these perceptions through lifestyle modification programs. Although several studies have evaluated causal attributions with regard to obesity, other domains of illness perception, such as the perceived consequences of obesity and perceived controllability, have not yet been studied. The aim of the current study was to explore perceptions regarding causes, consequences, control, concerns and time course of obesity of centrally obese adults, with and without an elevated cardiometabolic risk and with or without weight loss, 3 years after screening for metabolic syndrome, and to compare these perceptions.MethodsThree groups were selected from a longitudinal study dependent on the baseline and 3-year follow-up profiles: individuals with central obesity and metabolic syndrome at both time points (‘persistent cardiometabolic-risk group’, n = 80), those with central obesity but without metabolic syndrome on either occasion (‘persistent obese group’, n = 63), and formerly obese individuals (‘improved cardiometabolic-risk group’, n = 49). Perceptions of obesity were assessed using an adapted version of the Brief Illness Perception Questionnaire (BIPQ, range 0–10). Chi-square and Kruskal-Wallis tests were performed to compare the ‘persistent cardiometabolic risk’ group with the other two groups with regard to patient characteristics and BIPQ scores.ResultsBoth males and females who improved their cardiometabolic risk perceived their obesity as shorter (median (IQR): 3.0 (4.0) vs. 6.0 (3.0), p < 0.001) and experienced greater personal control over their weight (7.0 (3.0) vs. 5.0 (3.0), p = 0.002) compared to those who did not improve. Females who improved their cardiometabolic risk experienced fewer identity and illness concerns, this was not found for males. Other scores did not differ between groups.ConclusionObese adults with an improved cardiometabolic risk profile felt greater personal control and considered their obesity to be of shorter duration. Persistence of central obesity with additional cardiometabolic risk factors had a larger impact on female than male participants with respect to identity and illness concerns. Whether discussing ‘personal control’ is a favourable element in lifestyle intervention should now be assessed in the setting of a controlled trial.


Diabetic Medicine | 2018

The effectiveness of an emotion-focused educational programme in reducing diabetes distress in adults with Type 2 diabetes mellitus (VEMOFIT): a cluster randomized controlled trial

Boon How Chew; Rimke C. Vos; Rebecca K. Stellato; Mastura Ismail; Guy E.H.M. Rutten

To evaluate the effectiveness of a brief, value‐based emotion‐focused educational programme (VEMOFIT) in Malay adults with Type 2 diabetes mellitus compared with a programme of active listening to participants’ emotional experiences, social support and their opinion on the health clinic diabetes care services (attention control).


BMC Family Practice | 2018

Disentangling the effect of illness perceptions on health status in people with type 2 diabetes after an acute coronary event

Rimke C. Vos; Marise Kasteleyn; Monique Heijmans; Elke de Leeuw; F.G. Schellevis; Mieke Rijken; Guy Emile Rutten

BackgroundChronically ill patients such as people with type 2 diabetes develop perceptions of their illness, which will influence their coping behaviour. Perceptions are formed once a health threat has been recognised. Many people with type 2 diabetes suffer from multimorbidity, for example the combination with cardiovascular disease. Perceptions of one illness may influence perceptions of the other condition. The aim of the current study was to evaluate the effect of an intervention in type 2 diabetes patients with a first acute coronary event on change in illness perceptions and whether this mediates the intervention effect on health status. The current study is a secondary data analysis of a RCT.MethodsTwo hundred one participants were randomised (1:1 ratio) to the intervention (n = 101, three home visits) or control group (n = 100). Outcome variables were diabetes and acute coronary event perceptions, assessed with the two separate Brief Illness Perceptions Questionnaires (BIPQs); and health status (Euroqol Visual Analog Scale (EQ-VAS)). The intervention effect was analysed using ANCOVA. Linear regression analyses were used to assess whether illness perceptions mediated the intervention effect on health status.ResultsA positive intervention effect was found on the BIPQ diabetes items coherence and treatment control (F = 8.19, p = 0.005; F = 14.01, p < 0.001). No intervention effect was found on the other BIPQ diabetes items consequence, personal control, identity, illness concern and emotional representation. Regarding the acute coronary event, a positive intervention effect on treatment control was found (F = 7.81, p = 0.006). No intervention effect was found on the other items of the acute coronary event BIPQ. Better diabetes coherence was associated with improved health status, whereas perceiving more treatment control was not. The mediating effect of the diabetes perception ‘coherence’ on health status was not significant.ConclusionTargeting illness perceptions of people with diabetes after an acute coronary event has no effect on most domains, but can improve the perceived understanding of their diabetes. Discussing perceptions prevents people with type 2 diabetes who recently experienced an acute coronary event from the perception that they will lose control of both their diabetes and the acute coronary event. Illness perceptions of diabetes patients should therefore be discussed in the dynamic period after an acute coronary event.Trial registrationNederlands trial register; NTR3076, Registered September 20 2011.


JAMA | 2017

Oral Hypoglycemic Agents Added to Insulin Monotherapy for Type 2 Diabetes

Rimke C. Vos; Guy E.H.M. Rutten

Clinical Question Among patients with type 2 diabetes mellitus who do not achieve optimal glycemic control with insulin monotherapy, is the addition of oral hypoglycemic agents associated with benefits (measured by lowering of hemoglobin A1c) or adverse effects? Bottom Line Adding a sulfonylurea to insulin was associated with more hypoglycemic events compared with insulin alone, but this association was not observed for metformin. Adding a sulfonylurea or metformin to insulin was associated with a decrease in hemoglobin A1c of approximately 1.0%.


BMJ Open | 2017

What determines treatment satisfaction of patients with type 2 diabetes on insulin therapy? : An observational study in eight European countries

Anne Meike Boels; Rimke C. Vos; Tom G T Hermans; Nicolaas P.A. Zuithoff; N Müller; Kamlesh Khunti; Guy E.H.M. Rutten

Objective Patients with type 2 diabetes (T2DM) on insulin therapy are less satisfied with their diabetes treatment than those on oral hypoglycaemic therapies or lifestyle advice only. Determinants of satisfaction in patients with T2DM on insulin therapy are not clearly known. The aim of this study was to determine the association of treatment satisfaction with demographic and clinical characteristics of patients with T2DM. Design For this study we used data from the GUIDANCE (Guideline Adherence to Enhance Care) study, a cross-sectional study among 7597 patients with T2DM patients from Belgium, France, Germany, Ireland, Italy, Sweden, the Netherlands and the UK. The majority of patients were recruited from primary care. Treatment satisfaction was assessed by the Diabetes Treatment Satisfaction Questionnaire (DTSQ, score 0–36; higher scores reflecting higher satisfaction). To determine which patient characteristics and laboratory values were independently associated with treatment satisfaction, a linear mixed model analysis was used. Participants In total, 1984 patients on insulin were analysed; the number of included patients per country ranged from 166 (the Netherlands) to 384 (Italy). Results The mean DTSQ score was 28.50±7.52 and ranged from 25.93±6.57 (France) to 30.11±5.09 (the Netherlands). Higher DTSQ scores were associated with having received diabetes education (β 1.64, 95% CI 0.95 to 2.32), presence of macrovascular complications (β 0.76, 95% CI 0.21 to 1.31) and better health status (β 0.08 for every one unit increase on a 0–100 scale, 95% CI 0.07 to 0.10). Lower DTSQ scores were associated with more frequently perceived hyperglycaemia (β −0.32 for every 1 unit increase on a seven-point Likert scale, 95% CI −0.50 to −0.13), and higher glycated haemoglobin (β −0.52 for every percentage increase, 95% CI −0.75 to −0.29). Conclusions A number of factors including diabetes education, perceived and actual hyperglycaemia and macrovascular complications are associated with treatment satisfaction. Self-management education programmes should incorporate these factors for ongoing support in patients with T2DM.


Journal of Diabetes and Its Complications | 2016

Differences in clinical characteristics between patients with and without type 2 diabetes hospitalized with a first myocardial infarction

Marise Kasteleyn; Rimke C. Vos; Hanneke Jansen; Guy E.H.M. Rutten

AIMS To explore differences in clinical characteristics of patients with and without type 2 diabetes (T2DM) hospitalized with a first myocardial infarction (MI). METHODS In this cross-sectional study we examined differences between patients with and without T2DM hospitalized with a first MI (n=563). Multiple linear regression modeling was used to examine the association between T2DM and age of occurrence of MI. We adjusted for gender, systolic blood pressure (BP), lipids and creatinine level to examine whether these variables explained the association between T2DM and age of occurrence of MI. RESULTS Among 563 patients with a first MI, T2DM patients (n=77) were older than non-diabetic patients (67.8±10.9 vs. 64.4±13.4years, p<0.05), had lower LDL (2.5±0.8 vs. 3.4±1.1mmol/l, p<0.001) and total cholesterol levels (4.4±0.9 vs. 5.4±1.2mmol/l, p<0.001), but higher systolic BP (150.3±29.9 vs. 141.7±27.5mmHg, p<0.05). The association between T2DM and age of occurrence of MI was largely explained by cholesterol levels. CONCLUSIONS T2DM patients were older when hospitalized with a first MI. This difference was largely explained by differences in cholesterol levels. The lower cholesterol levels in T2DM patients compared to non-diabetic patients, and maybe also the older age of occurrence of MI, might reflect the results successful primary prevention and systematic monitoring in T2DM.

Collaboration


Dive into the Rimke C. Vos's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Boon How Chew

Universiti Putra Malaysia

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Marise Kasteleyn

Leiden University Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

F.G. Schellevis

VU University Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Aaron Fernandez

Universiti Putra Malaysia

View shared research outputs
Researchain Logo
Decentralizing Knowledge